Invention Grant
- Patent Title: HIF inhibitors and use thereof
-
Application No.: US14186294Application Date: 2014-02-21
-
Publication No.: US09604958B2Publication Date: 2017-03-28
- Inventor: Othon Iliopoulos , Michael Zimmer
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Main IPC: A61K31/381
- IPC: A61K31/381 ; A61K31/085 ; C07D333/22 ; C07D333/24 ; C07D335/02 ; A61K31/38 ; A61K31/138 ; A61K31/166 ; A61K31/167 ; A61K31/366 ; A61K31/382 ; A61K31/473 ; A61K31/5575 ; A61K45/06 ; C07C225/16 ; C07C235/38 ; C07C237/46 ; C07D219/14 ; C07D309/38 ; C07D333/38
Abstract:
The present invention is directed to HIF inhibitors and methods of preventing cell proliferation, reducing inflammation, and treating an angiogenic disease or disorders.
Public/Granted literature
- US20150023868A1 HIF INHIBITORS AND USE THEREOF Public/Granted day:2015-01-22
Information query
